Searched for
NATCOPHARMA LIMITED
Indian biotech firm develops world’s first, indigenous Bi-Specific 3rd generation CAR T cells for cancer treatmentThis therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly r...18 Mar, 2025, 04.22 PM IST- Natco Pharma proposes to acquire Dash PharmaceuticalsAccording to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution...14 Dec, 2021, 04.16 PM IST
- RBI okays foreign investors to up stake in Natco Pharma to 49 per centForeign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) can now invest from 31.50 per cent to 49 per cent of the paid up...15 May, 2017, 10.12 PM IST
- Buy Natco Pharma Ltd. with a target of Rs 750 – Kotak Securities LimitedBuy Natco Pharma Ltd. with a target of Rs 750. The stock, Kotak Securities believes will continue to trade at higher multiples given the ev...30 Dec, 2016, 09.27 AM IST
- Cancer medicines, antibiotics become cheaper as NPPA slashes pricesNPPA has also revised the prices of several cancer drugs in its latest list, including vincristine, bleomycin, cyclophosphamide and dacarba...08 Oct, 2016, 10.21 PM IST
- Buy Natco Pharma., target Rs 690 : Shrikant ChouhanBuy Natco Pharma Ltd. at a price target of Rs 690.0 and a stop loss at Rs 610.0 from entry point12 Aug, 2016, 08.31 AM IST
- Natco settles patent litigation with Celgene on cancer drugNatco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment...23 Dec, 2015, 02.23 PM IST
- RBI move allows foreign investors to buy more shares in IndusInd BankThe Reserve Bank has removed IndusInd Bank from its caution list, allowing foreign investors to buy further shares in the lender.04 Sep, 2015, 08.25 PM IST
- Natco Pharma Q1 net profit dips 16% to Rs 28.23 croreNatco Pharma today reported 15.63 per cent dip in consolidated net profit to Rs 28.23 crore for the first quarter ended June 30, 2015-16.12 Aug, 2015, 09.35 PM IST
- US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...19 Jun, 2015, 04.00 PM IST
- Natco Pharma mulls hiking foreign institutional investors limit to 49 per cent, looks to raise fundsNatco said in a BSE filing that the company's board will meet on May 22 to consider and approve proposals over hiking of FII limit and rais...12 May, 2015, 02.20 PM IST
- Natco Pharma shares surge over 9 per centThe stock gained sharply by 9.09 per cent to settle at Rs 1,792.05 on the BSE. During the day, it jumped 10.48 per cent to Rs 1,815 -- its ...11 Mar, 2015, 09.53 PM IST
- Natco Pharma ties up with Gilead on hepatitis C drugsNatco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.02 Mar, 2015, 12.32 PM IST
- Natco Pharma Q3 net profit declines by 52 per centNet sales of company declined by 1.02 per cent to Rs 184.27 crore during period under review as against Rs 186.18 crore of same period last...11 Feb, 2015, 06.54 PM IST
- Natco hits peak on stake buy by CX Securities"We will use the fund for general corporate purposes and to service our debt," N Adinarayan, company secretary at Natco Pharma, said in the...22 Oct, 2013, 04.19 AM IST
- India lawyers bag Antitrust Writing AwardTwo young Indian lawyers today bagged the prestigious Antitrust Writing Award for their article on "compulsary licensing in India".10 Apr, 2013, 03.18 PM IST
- Natco Pharma introduces Lenalidomide genericNatco Pharma has introduced the generic version of Lenalidomide, which is indicated for the treatment of Myelo Dysplastic Syndrome.11 Sep, 2007, 02.40 PM IST
Load More
